Francesca Galvani

7PUBLICATIONS
21CO-AUTHORS
Biomolecular modelling and designMolecular targetsHaematological tumoursBasic pharmacologyCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 17, 2025
JAK3 Inhibitors: Covalent and Noncovalent Interactions of a Cyanamide Group Investigated by Multiscale Free-Energy Simulations.

Laura Scalvini, Daniele Pala, Alberto Cuzzolin

|Nov 25, 2024
Protective Activity of Melatonin Combinations and Melatonin-Based Hybrid Molecules in Neurodegenerative Diseases.

Francesca Galvani, Mariarosaria Cammarota, Federica Vacondio

|Jul 18, 2024
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood Malignancies.

Gabriele Carullo, Sara Rossi, Valentina Giudice

|Nov 01, 2023
Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity.

Lorenzo Guidetti, Alfonso Zappia, Laura Scalvini

|Apr 13, 2023
Unbinding Kinetics of Muscarinic M3 Receptor Antagonists Explained by Metadynamics Simulations.

Francesca Galvani, Daniele Pala, Alberto Cuzzolin

|Feb 10, 2023
Mechanistic Modeling of Lys745 Sulfonylation in EGFR C797S Reveals Chemical Determinants for Inhibitor Activity and Discriminates Reversible from Irreversible Agents.

Kemel Arafet, Laura Scalvini, Francesca Galvani

Pageof 2

Frequent Collaborators

6 joint publications

Alessio Lodola

6 joint publications

Marco Mor

5 joint publications

Laura Scalvini

4 joint publications

Silvia Rivara